Targeting rare diseases

    Medchemcomm
    |August 16, 2018
    PubMed

    Insights

    Focusing on rare genetic mutations, even those affecting few individuals, is a viable research strategy. Such studies are crucial for understanding disease mechanisms and developing targeted therapies for underserved populations.

    Area of Science:

    • Genetics and genomics
    • Rare disease research
    • Molecular biology

    Background:

    • Investigating genetic mutations with low prevalence presents unique challenges.
    • Understanding the genetic basis of rare diseases is critical for medical advancement.
    • The study explores the strategic value of focusing on infrequent genetic variations.

    Discussion:

    • Despite low frequency, these mutations can reveal fundamental biological pathways.
    • Research into rare genetic conditions can yield insights applicable to broader populations.
    • The potential for significant therapeutic breakthroughs justifies the focus on rare mutations.

    Key Insights:

    • Rare genetic mutations offer valuable insights into complex biological systems.
    • Targeted research on infrequent genetic variations can lead to novel therapeutic strategies.
    • The impact of rare genetic diseases necessitates dedicated scientific investigation.

    Outlook:

    • Continued research into rare genetic mutations will expand our understanding of human health.
    • Advancements in genomic technologies facilitate the study of low-prevalence genetic conditions.
    • Future therapeutic developments may arise from exploring these unique genetic landscapes.

    Related Concept Videos

    Inflammatory Bowel Disease II: Crohn's Disease01:30

    Inflammatory Bowel Disease II: Crohn's Disease

    Introduction
    Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
    Crohn's disease
    Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
    1.1K
    Immunodeficiency Diseases01:25

    Immunodeficiency Diseases

    Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
    There are three main causes of immunodeficiency...
    2.4K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    8.9K
    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
    1.2K
    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    963
    Principles of Disease Surveillance01:26

    Principles of Disease Surveillance

    Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
    560